Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

VRTX

Vertex Pharmaceuticals, Inc.

Oct 03 • 10:08AM ET

461.09

Dollar change -1.05
Percentage change -0.23	%

Healthcare • Biotechnology • USA • NASD

Held by: VTI VOO QQQ SPY IVV VUG XLV IBB VHT JEPI

Scroll to Statements

Index	NDX, S&P 500	P/E	-	EPS (ttm)	-2.03	Insider Own	0.26%	Shs Outstand	257.70M	Perf Week	-0.44%
Market Cap	119.01B	Forward P/E	24.81	EPS next Y	18.59	Insider Trans	-13.01%	Shs Float	257.43M	Perf Month	-3.65%
Income	-489.90M	PEG	-	EPS next Q	4.05	Inst Own	92.71%	Short Float	1.68%	Perf Quarter	-2.84%
Sales	10.32B	P/S	11.53	EPS this Y	-97.83%	Inst Trans	1.21%	Short Ratio	4.03	Perf Half Y	14.13%
Book/sh	57.26	P/B	8.05	EPS next Y	5516.30%	ROA	-2.42%	Short Interest	4.34M	Perf Year	33.59%
Cash/sh	22.45	P/C	20.53	EPS next 5Y	12.33%	ROE	-3.24%	52W Range	341.85 - 510.64	Perf YTD	13.32%
Dividend Est.	-	P/FCF	-	EPS past 5Y	11.42%	ROI	-3.12%	52W High	-9.70%	Beta	0.40
Dividend TTM	-	Quick Ratio	2.26	Sales past 5Y	27.16%	Gross Margin	86.43%	52W Low	34.88%	ATR (14)	8.76
Dividend Ex-Date	-	Current Ratio	2.52	EPS Y/Y TTM	-114.46%	Oper. Margin	-3.79%	RSI (14)	41.03	Volatility	1.65% 1.87%
Employees	5400	Debt/Eq	0.06	Sales Y/Y TTM	10.32%	Profit Margin	-4.75%	Recom	1.94	Target Price	517.65
Option/Short	Yes / Yes	LT Debt/Eq	0.06	EPS Q/Q	-495.94%	Payout	0.00%	Rel Volume	0.45	Prev Close	462.14
Sales Surprise	-0.68%	EPS Surprise	-10.36%	Sales Q/Q	6.02%	Earnings	Aug 01 AMC	Avg Volume	1.08M	Price	461.09
SMA20	-2.03%	SMA50	-3.58%	SMA200	3.77%	Trades		Volume	68,684	Change	-0.23%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-05-24	Downgrade	Barclays	Overweight → Equal Weight	$472 → $509
Jun-27-24	Initiated	Redburn Atlantic	Buy	$545
Apr-11-24	Upgrade	Evercore ISI	In-line → Outperform	$438
Feb-15-24	Initiated	Wolfe Research	Outperform	$515
Feb-06-24	Downgrade	Evercore ISI	Outperform → In-line	$436 → $438
Feb-02-24	Downgrade	Bernstein	Outperform → Mkt Perform
Jan-31-24	Downgrade	Robert W. Baird	Neutral → Underperform	$325
Jan-31-24	Downgrade	Maxim Group	Buy → Hold
Jan-24-24	Downgrade	Canaccord Genuity	Hold → Sell	$332 → $379
Dec-14-23	Reiterated	RBC Capital Mkts	Sector Perform	$347 → $379
May-30-23	Initiated	William Blair	Outperform	$382
May-04-23	Resumed	Piper Sandler	Overweight	$385
Mar-21-23	Initiated	Bernstein	Outperform	$344
Jan-18-23	Initiated	Canaccord Genuity	Hold	$311
Jan-17-23	Upgrade	SVB Leerink	Mkt Perform → Outperform	$374
Dec-19-22	Downgrade	Jefferies	Buy → Hold	$340
Jul-13-22	Initiated	Cantor Fitzgerald	Overweight	$365
Jun-01-22	Upgrade	Maxim Group	Hold → Buy	$325
May-23-22	Initiated	SVB Leerink	Mkt Perform	$265
May-06-22	Downgrade	Robert W. Baird	Outperform → Neutral	$250

Show Previous Ratings

Oct-01-24 05:00AM	5 FDA decisions to watch in the fourth quarter (BioPharma Dive)
Sep-30-24 06:00PM	Vertex Pharmaceuticals (VRTX) Surpasses Market Returns: Some Facts Worth Knowing (Zacks)
Sep-27-24 07:31AM	Vertex Pharmaceuticals presents vanzacaftor/tezacaftor/deutivacaftor data (TipRanks)
Sep-26-24 09:30AM	Wall Street Analysts See Vertex (VRTX) as a Buy: Should You Invest? (Zacks)
09:00AM	Vertex Announces Health Canada Acceptance of New Drug Submission for Vanzacaftor/Tezacaftor/Deutivacaftor, a Next-in-Class Triple Combination Treatment for Cystic Fibrosis (PR Newswire)
07:07AM	Loading…
07:07AM	Vertex Highlights First Oral Presentation of Phase 3 Clinical Data of the Vanza Triple and New Data on Long-Term Impact of TRIKAFTA at the North American Cystic Fibrosis Conference (Business Wire)
Sep-25-24 03:50PM	Health Canada Grants Marketing Authorization of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY® (Exagamglogene Autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia (PR Newswire)
09:00AM	Is Trending Stock Vertex Pharmaceuticals Incorporated (VRTX) a Buy Now? (Zacks)
Sep-23-24 06:00PM	Vertex Pharmaceuticals (VRTX) Stock Declines While Market Improves: Some Information for Investors (Zacks)
Sep-22-24 05:50AM	The Best Biotech Stock to Invest $1,000 in Right Now (Motley Fool)
Sep-21-24 10:15AM	Bull Market and Beyond: 2 Stocks Just Waiting to Soar (Motley Fool)
07:36AM	3 Dirt Cheap Stocks to Buy Right Now (Motley Fool)
Sep-19-24 05:07PM	The best biotech plays outside the GLP-1 weight-loss market (Yahoo Finance Video)
Sep-18-24 05:49AM	Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030 (Motley Fool)
Sep-16-24 06:00PM	Vertex Pharmaceuticals (VRTX) Beats Stock Market Upswing: What Investors Need to Know (Zacks)
07:30AM	Loading…
Sep-14-24 07:30AM	3 Stocks to Buy and Hold Forever (Motley Fool)
05:42AM	Prediction: These 3 Phenomenal Stocks Are Set to Soar (Motley Fool)
Sep-13-24 02:45PM	Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics (Benzinga)
09:00AM	Is Most-Watched Stock Vertex Pharmaceuticals Incorporated (VRTX) Worth Betting on Now? (Zacks)
Sep-12-24 08:45AM	1 Biotech Stock Down 62% to Buy and Hold (Motley Fool)
Sep-10-24 05:50PM	Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: What You Should Know (Zacks)
Sep-08-24 01:58AM	Vertex Pharmaceuticals Incorporated (VRTX): Why Do Hedge Funds Recommend This Biotech Stock? (Insider Monkey)
Sep-02-24 09:00AM	Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
07:12AM	Is DexCom a Millionaire-Maker Stock? (Motley Fool)
Aug-31-24 07:30AM	3 No-Brainer Stocks to Buy in September (Motley Fool)
Aug-30-24 08:19PM	Vertex Pharmaceutical Inc. (VRTX): Jim Cramer's Go-To Stock For Success (Insider Monkey)
06:45AM	3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever (Motley Fool)
05:50AM	3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow (Motley Fool)
Aug-28-24 06:19PM	Here's Why a Handful of Pharmaceutical Stocks Rose Wednesday (Investopedia)
Aug-23-24 05:45AM	Forget Novo Nordisk: Buy This Magnificent Pharma Stock Instead (Motley Fool)
08:00AM	Loading…
Aug-22-24 08:00AM	Vertex to Participate in Upcoming September Investor Conferences (Business Wire)
Aug-21-24 09:00AM	Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Aug-18-24 05:00AM	These 2 Incredible Growth Stocks Are Set to Soar This Summer and Beyond (Motley Fool)
Aug-17-24 03:58PM	Why Is Royalty Pharma plc (RPRX) the Best Defensive Stock to Buy Now? (Insider Monkey)
07:30AM	3 Fantastic Growth Stocks to Buy in August (Motley Fool)
Aug-15-24 08:02AM	Vertex (VRTX) Stock Outperforms Industry YTD: Here's Why (Zacks)
05:45AM	Prediction: These 4 Future Technologies Will Be Millionaire-Makers -- and Here Are the Top Stocks to Buy Now to Profit From Them (Motley Fool)
Aug-12-24 09:30AM	2 Biotech Stocks to Buy Hand Over Fist in August (Motley Fool)
Aug-08-24 07:22PM	Insider Sale at Vertex Pharmaceuticals Inc (VRTX) by EVP and CMO Carmen Bozic (GuruFocus.com)
01:53PM	CRISPR-based Casgevy is made accessible in England following NICE guidance (Pharmaceutical Technology)
12:23PM	Merck TIGIT drug fails another trial; Intellia therapy succeeds in HAE study (BioPharma Dive)
11:07AM	Here's How to Play Vertex (VRTX) Stock After Q2 Loss, Price Dip (Zacks)
Aug-07-24 07:12PM	Vertex Announces CASGEVY Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia in England (Business Wire)
Aug-06-24 09:00AM	Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know (Zacks)
04:31AM	Is It Too Late to Buy Vertex Pharmaceuticals Stock? (Motley Fool)
Aug-05-24 05:52PM	Google's search monopoly, El-Erian talks the Fed: Market Domination (Yahoo Finance Video)
04:59PM	Investing in biotech outside of weight-loss drugs (Yahoo Finance Video)
06:55AM	Prediction: These Could Be the Best-Performing Growth Stocks Through 2030 (Motley Fool)
Aug-04-24 01:33PM	3 Biotech Stocks on Track for 50% Returns (or More) by 2028 (InvestorPlace)
Aug-03-24 07:45AM	3 Unstoppable Stocks to Buy in August (Motley Fool)
06:38AM	Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now (Motley Fool)
01:02AM	Decoding Vertex Pharmaceuticals Inc (VRTX): A Strategic SWOT Insight (GuruFocus.com)
Aug-02-24 06:00PM	Compared to Estimates, Vertex (VRTX) Q2 Earnings: A Look at Key Metrics (Zacks)
05:25PM	Analyst Report: Vertex Pharmaceuticals Incorporated (Morningstar Research)
10:03AM	Vertex (VRTX) Q2 Loss Wider Than Expected, '24 Sales View Raised (Zacks)
05:50AM	Should Investors Worry About Vertex Pharmaceuticals $3.6 Billion Q2 Loss? Not Even for a Second. (Motley Fool)
Aug-01-24 09:30PM	Vertex Pharmaceuticals (VRTX) Q2 2024 Earnings Call Transcript (Motley Fool)
05:15PM	Vertex Pharmaceuticals (VRTX) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:53PM	Vertex Slumps As Guidance Hike Featuring The Gene-Editing Launch Fails To Erase Losses (Investor's Business Daily)
04:11PM	Vertex: Q2 Earnings Snapshot (Associated Press Finance)
04:10PM	Vertex Slumps On Light Second-Quarter Despite Hiked 2024 Outlook (Investor's Business Daily)
04:08PM	Vertex Pharma raises annual revenue forecast on strong demand for its cystic fibrosis treatments (Reuters)
04:01PM	Vertex Reports Second Quarter 2024 Financial Results (Business Wire)
10:15AM	Got $500? 2 Compelling Growth Stocks to Buy and Hold Forever (Motley Fool)
Jul-30-24 01:10PM	Vertex Announces FDA Acceptance of New Drug Application for Suzetrigine for the Treatment of Moderate-to-Severe Acute Pain (Business Wire)
Jul-29-24 10:44AM	Vertex (VRTX) Stock Before Q2 Earnings: To Buy or Not to Buy? (Zacks)
09:16AM	Curious about Vertex (VRTX) Q2 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
Jul-28-24 04:41AM	2 No-Brainer Growth Stocks to Buy With $1,000 Right Now (Motley Fool)
Jul-25-24 07:20PM	Insider Sale at Vertex Pharmaceuticals Inc (VRTX) by EVP and CMO Carmen Bozic (GuruFocus.com)
01:01PM	Baillie Gifford's Strategic Moves in Q2 2024: A Closer Look at NVIDIA Corp's Impact (GuruFocus.com)
08:15AM	Is Vertex Pharmaceuticals' Monopoly in Danger? (Motley Fool)
04:10AM	3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow (Motley Fool)
Jul-24-24 07:01PM	Insider Sale: CEO & President Reshma Kewalramani Sells 15,202 Shares of Vertex ... (GuruFocus.com)
05:50PM	Vertex Pharmaceuticals (VRTX) Rises As Market Takes a Dip: Key Facts (Zacks)
09:00AM	Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock (Zacks)
03:52AM	Pipeline power: Sionnas AbbVie deal could redefine CF therapeutics (Pharmaceutical Technology)
Jul-23-24 01:54PM	HHS gives thumbs down to bluebirds fertility support programme (Pharmaceutical Technology)
Jul-22-24 06:00PM	Here's Why Vertex Pharmaceuticals (VRTX) Gained But Lagged the Market Today (Zacks)
Jul-21-24 05:06AM	2 Historically Flawless Metrics Suggest the Stock Market Can Plunge: Here Are 3 Stocks I've Sold Ahead of What May Be a Big Move for Wall Street (Motley Fool)
Jul-20-24 06:00AM	3 Monster Stocks in the Making to Buy Right Now (Motley Fool)
Jul-17-24 01:30PM	3 Gene Editing Stocks That Could Grow Your Wealth (InvestorPlace)
Jul-16-24 09:15AM	Genomics plc Announces New Extension and Expansion of Drug Discovery Collaboration with Vertex (PR Newswire)
08:00AM	Vertex taps Orum to hunt for better preconditioning drugs (BioPharma Dive)
04:15AM	Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals? (Motley Fool)
Jul-15-24 06:00PM	Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider (Zacks)
09:00AM	Health Canada Grants Marketing Authorization for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for People With Cystic Fibrosis Aged 2 Years and Older With Certain Rare Mutations (PR Newswire)
07:15AM	Bull Market and Beyond: 2 Stocks Just Waiting to Soar (Motley Fool)
04:15AM	Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split (Motley Fool)
Jul-14-24 09:15AM	Got $1,000? 2 Incredible Growth Stocks to Buy and Hold Forever (Motley Fool)
Jul-12-24 07:01PM	Insider Sale: EVP and CMO Carmen Bozic Sells Shares of Vertex Pharmaceuticals Inc (VRTX) (GuruFocus.com)
Jul-11-24 08:45AM	1 Biotech Stock to Buy Hand Over Fist and 1 to Avoid (Motley Fool)
Jul-09-24 06:00PM	Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know (Zacks)
07:00AM	The 3 Most Undervalued Gene Editing Stocks to Buy in July 2024 (InvestorPlace)
Jul-08-24 08:00AM	3 No-Brainer Stocks to Buy in July (Motley Fool)
06:00AM	3 Pharma Stocks Already Ushering in the Next Biotech Boom (InvestorPlace)
Jul-06-24 04:15AM	Prediction: This Will Be Vertex Pharmaceuticals' New Billion-Dollar Growth Driver (and It's Coming Soon). (Motley Fool)
Jul-05-24 02:14PM	The 3 Best Biotech Stocks to Buy in July 2024 (InvestorPlace)
07:45AM	1 Stock That Increased 10,000% in 33 Years to Buy and Hold Forever (Motley Fool)
05:45AM	Did Vertex Pharmaceuticals Just Invent the Next Ozempic? (Motley Fool)
Jul-04-24 05:50AM	Forget Eli Lilly: 3 Biotech Stocks to Buy Instead (Motley Fool)

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Biller Jonathan	Officer	Oct 02 '24	Proposed Sale	461.66	999	461,198		Oct 02 10:04 AM
LEIDEN JEFFREY M	Executive Chairman	Aug 30 '24	Sale	499.00	3,784	1,888,216	9,994	Sep 04 04:13 PM
Bhatia Sangeeta N.	Director	Aug 30 '24	Option Exercise	152.74	646	98,670	5,081	Sep 04 04:12 PM
Bhatia Sangeeta N.	Director	Aug 30 '24	Sale	500.00	646	323,000	4,435	Sep 04 04:12 PM
Bhatia Sangeeta N.	Director	Aug 30 '24	Proposed Sale	500.00	646	323,000		Aug 30 04:47 PM
JEFFREY LEIDEN	Director	Aug 30 '24	Proposed Sale	493.35	3,784	1,866,836		Aug 30 04:23 PM
Bhatia Sangeeta N.	Director	Aug 08 '24	Option Exercise	152.74	1,292	197,340	5,727	Aug 12 04:08 PM
Bhatia Sangeeta N.	Director	Aug 08 '24	Sale	466.29	1,292	602,447	4,435	Aug 12 04:08 PM
Bozic Carmen	EVP and CMO	Aug 07 '24	Sale	476.75	2,280	1,086,990	23,259	Aug 08 04:06 PM
Bhatia Sangeeta N.	Director	Aug 08 '24	Proposed Sale	466.29	1,292	602,447		Aug 08 11:47 AM
Bozic Carmen	Officer	Aug 07 '24	Proposed Sale	476.75	2,280	1,086,990		Aug 07 09:52 AM
SACHS BRUCE I	Director	Aug 01 '24	Option Exercise	125.71	5,295	665,634	45,295	Aug 02 04:10 PM
SACHS BRUCE I	Director	Aug 01 '24	Sale	508.00	5,295	2,689,860	40,000	Aug 02 04:10 PM
Kewalramani Reshma	CEO & President	Jul 30 '24	Sale	505.00	15,202	7,677,010	90,970	Aug 01 04:17 PM
SACHS BRUCE I	Director	Aug 01 '24	Proposed Sale	508.00	5,295	2,689,860		Aug 01 03:34 PM
Kewalramani Reshma	Officer	Jul 30 '24	Proposed Sale	505.00	15,202	7,677,010		Jul 30 03:25 PM
Bozic Carmen	EVP and CMO	Jul 24 '24	Sale	488.46	2,280	1,113,689	25,539	Jul 25 04:06 PM
Kewalramani Reshma	CEO & President	Jul 22 '24	Sale	497.00	15,202	7,555,394	106,172	Jul 24 04:05 PM
Bozic Carmen	EVP and CMO	Jul 10 '24	Sale	487.34	2,280	1,111,135	27,819	Jul 12 04:07 PM
Bozic Carmen	EVP and CMO	Jun 26 '24	Sale	471.72	2,280	1,075,522	30,099	Jun 28 04:04 PM
Bozic Carmen	EVP and CMO	Jun 12 '24	Sale	478.00	2,280	1,089,840	32,379	Jun 13 04:11 PM
Atkinson Edward Morrow III	EVP, Chief Technical Ops. Off.	Jun 12 '24	Sale	478.00	7,288	3,483,664	15,972	Jun 13 04:09 PM
WAGNER CHARLES F JR	EVP & Chief Financial Officer	Jun 03 '24	Sale	460.00	3,250	1,495,000	47,137	Jun 05 04:11 PM
Tatsis Ourania	EVP, Chief Reg. & Quality Off.	Jun 03 '24	Sale	460.00	2,175	1,000,500	49,098	Jun 05 04:08 PM
Tatsis Ourania	EVP, Chief Reg. & Quality Off.	May 30 '24	Sale	439.11	2,350	1,031,908	53,523	Jun 03 04:09 PM
Tatsis Ourania	EVP, Chief Reg. & Quality Off.	May 31 '24	Sale	445.00	2,250	1,001,250	51,273	Jun 03 04:09 PM
Bozic Carmen	EVP and CMO	May 29 '24	Sale	445.56	2,280	1,015,877	34,659	May 31 04:19 PM
WAGNER CHARLES F JR	EVP & Chief Financial Officer	May 28 '24	Sale	454.79	3,250	1,478,068	50,387	May 30 04:07 PM
Kewalramani Reshma	CEO & President	May 24 '24	Option Exercise	187.53	1,565	293,484	122,939	May 29 04:08 PM
Kewalramani Reshma	CEO & President	May 24 '24	Sale	457.00	1,565	715,205	121,374	May 29 04:08 PM
SACHS BRUCE I	Director	May 22 '24	Option Exercise	93.51	7,073	661,396	47,073	May 24 04:13 PM
SACHS BRUCE I	Director	May 22 '24	Sale	448.00	7,073	3,168,704	40,000	May 24 04:13 PM
Kewalramani Reshma	CEO & President	May 20 '24	Sale	447.00	15,202	6,795,294	121,374	May 22 04:21 PM
Sachdev Amit	EVP Chief Patient & Ext Af Off	May 15 '24	Sale	430.93	32	13,790	55,325	May 17 04:27 PM
Arbuckle Stuart A	EVP, COO	May 15 '24	Sale	430.93	69	29,734	49,691	May 17 04:24 PM
ALTSHULER DAVID	EVP, Chief Scientific Officer	May 15 '24	Sale	430.93	54	23,270	25,813	May 17 04:22 PM
Bhatia Sangeeta N.	Director	May 02 '24	Sale	402.95	467	188,178	4,435	May 03 04:05 PM
Ambrose Kristen	SVP & Chief Accounting Officer	Apr 02 '24	Sale	419.00	240	100,560	7,500	Apr 03 04:02 PM
Tatsis Ourania	EVP, Chief Reg. & Quality Off.	Feb 26 '24	Sale	425.70	354	150,698	55,804	Feb 27 05:02 PM
Sachdev Amit	EVP Chief Patient & Ext Af Off	Feb 26 '24	Sale	425.70	3,004	1,278,803	55,325	Feb 27 04:59 PM
Atkinson Edward Morrow III	EVP, Chief Technical Ops. Off.	Feb 26 '24	Sale	425.70	883	375,893	15,972	Feb 27 04:44 PM
Arbuckle Stuart A	EVP, COO	Feb 26 '24	Sale	425.70	5,034	2,142,974	49,691	Feb 27 04:37 PM
Ambrose Kristen	SVP & Chief Accounting Officer	Feb 26 '24	Sale	425.70	883	375,893	7,965	Feb 27 04:29 PM
ALTSHULER DAVID	EVP, Global Research and CSO	Feb 26 '24	Sale	425.70	4,239	1,804,542	25,813	Feb 27 04:24 PM
Tatsis Ourania	EVP, Chief Reg. & Quality Off.	Feb 21 '24	Sale	421.77	360	151,837	59,467	Feb 23 04:28 PM
Sachdev Amit	EVP Chief Patient & Ext Af Off	Feb 21 '24	Sale	421.77	3,191	1,345,868	60,798	Feb 23 04:20 PM
Atkinson Edward Morrow III	EVP, Chief Technical Ops. Off.	Feb 21 '24	Sale	421.77	1,201	506,546	18,509	Feb 23 04:16 PM
Arbuckle Stuart A	EVP, COO	Feb 21 '24	Sale	421.77	3,603	1,519,637	59,439	Feb 23 04:12 PM
ALTSHULER DAVID	EVP, Global Research and CSO	Feb 21 '24	Sale	421.77	3,002	1,266,154	34,022	Feb 23 04:10 PM
Tatsis Ourania	EVP, Chief Reg. & Quality Off.	Feb 20 '24	Sale	420.79	480	201,979	59,827	Feb 21 04:43 PM
Sachdev Amit	EVP Chief Patient & Ext Af Off	Feb 20 '24	Sale	420.79	4,254	1,790,041	63,989	Feb 21 04:38 PM
Atkinson Edward Morrow III	EVP, Chief Technical Ops. Off.	Feb 20 '24	Sale	420.79	801	337,053	19,710	Feb 21 04:23 PM
Arbuckle Stuart A	EVP, COO	Feb 20 '24	Sale	420.79	4,804	2,021,475	63,042	Feb 21 04:19 PM
ALTSHULER DAVID	EVP, Global Research and CSO	Feb 20 '24	Sale	420.79	4,002	1,684,002	37,024	Feb 21 04:13 PM
LEIDEN JEFFREY M	Executive Chairman	Feb 15 '24	Sale	419.16	4,655	1,951,190	17,896	Feb 16 04:07 PM
LEIDEN JEFFREY M	Executive Chairman	Feb 14 '24	Sale	419.04	4,356	1,825,338	22,551	Feb 16 04:07 PM
LEIDEN JEFFREY M	Executive Chairman	Feb 12 '24	Sale	419.51	2,656	1,114,205	27,644	Feb 14 04:04 PM
LEIDEN JEFFREY M	Executive Chairman	Feb 13 '24	Sale	419.13	737	308,899	26,907	Feb 14 04:04 PM
Sachdev Amit	EVP Chief Patient & Ext Af Off	Feb 12 '24	Sale	420.24	3,222	1,354,013	74,364	Feb 13 05:15 PM
Biller Jonathan	EVP and Chief Legal Officer	Feb 12 '24	Sale	418.77	1,738	727,822	18,280	Feb 13 04:56 PM
Atkinson Edward Morrow III	EVP, Chief Technical Ops. Off.	Feb 12 '24	Sale	420.24	913	383,679	23,137	Feb 13 04:54 PM
Arbuckle Stuart A	EVP, COO	Feb 12 '24	Sale	420.24	4,295	1,804,931	75,718	Feb 13 04:51 PM
Ambrose Kristen	SVP & Chief Accounting Officer	Feb 12 '24	Sale	420.24	1,374	577,410	9,676	Feb 13 04:48 PM
ALTSHULER DAVID	EVP, Global Research and CSO	Feb 12 '24	Sale	420.24	3,145	1,321,655	47,588	Feb 13 04:46 PM
LEIDEN JEFFREY M	Executive Chairman	Jan 08 '24	Sale	419.07	6,648	2,785,977	2,423	Jan 10 04:06 PM
WAGNER CHARLES F JR	EVP & Chief Financial Officer	Jan 02 '24	Sale	405.00	3,000	1,215,000	43,693	Jan 04 04:17 PM
Kewalramani Reshma	CEO & President	Dec 15 '23	Option Exercise	181.83	17,135	3,115,593	125,846	Dec 19 04:15 PM
Kewalramani Reshma	CEO & President	Dec 15 '23	Sale	407.00	17,135	6,973,945	108,711	Dec 19 04:15 PM
LEIDEN JEFFREY M	Executive Chairman	Dec 13 '23	Sale	399.42	13,354	5,333,799	9,071	Dec 15 04:33 PM
Kewalramani Reshma	CEO & President	Dec 13 '23	Sale	397.00	5,098	2,023,906	108,711	Dec 15 04:23 PM
Arbuckle Stuart A	EVP, COO	Dec 13 '23	Option Exercise	187.53	8,603	1,613,321	65,159	Dec 15 04:20 PM
Arbuckle Stuart A	EVP, COO	Dec 13 '23	Sale	399.00	8,603	3,432,597	56,556	Dec 15 04:20 PM
WAGNER CHARLES F JR	EVP & Chief Financial Officer	Nov 20 '23	Sale	349.88	3,000	1,049,640	46,693	Nov 21 04:07 PM
Sachdev Amit	EVP Chief Patient & Ext Af Off	Nov 15 '23	Sale	369.92	35	12,947	58,814	Nov 17 04:16 PM
ALTSHULER DAVID	EVP, Global Research and CSO	Nov 15 '23	Sale	369.92	19	7,028	32,038	Nov 17 04:11 PM
Bozic Carmen	EVP and CMO	Nov 14 '23	Sale	380.82	5,650	2,151,633	29,302	Nov 16 04:15 PM
Kewalramani Reshma	CEO & President	Nov 13 '23	Sale	377.00	5,097	1,921,569	113,809	Nov 15 04:16 PM
SACHS BRUCE I	Director	Nov 06 '23	Option Exercise	127.54	11,250	1,434,825	51,250	Nov 08 04:11 PM
SACHS BRUCE I	Director	Nov 06 '23	Sale	385.00	11,250	4,331,250	40,000	Nov 08 04:11 PM
Bozic Carmen	EVP and CMO	Oct 31 '23	Sale	355.92	5,651	2,011,304	34,952	Nov 02 04:07 PM
Bozic Carmen	EVP and CMO	Oct 17 '23	Sale	373.25	5,651	2,109,236	40,603	Oct 19 04:18 PM
Bhatia Sangeeta N.	Director	Oct 17 '23	Sale	375.00	243	91,125	3,901	Oct 19 04:13 PM
LEIDEN JEFFREY M	Executive Chairman	Oct 16 '23	Sale	374.00	12,962	4,847,788	22,425	Oct 18 04:17 PM
Bhatia Sangeeta N.	Director	Oct 06 '23	Sale	360.00	242	87,120	4,144	Oct 11 04:14 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

VRTX

Vertex Pharmaceuticals, Inc.

Upgrade your FINVIZ experience